Our Investment in the Future of GI
Phathom is proud support a broad range of programs that offer support and resources to researchers, healthcare providers, patients and their advocates, as well as our local communities.
Phathom will consider funding initiatives in the general therapeutic area of acid-related gastrointestinal disorders, where our current areas of focus are:
Helicobacter pylori infection (H. pylori)
Gastroesophageal Reflux Disease (GERD), inclusive of Erosive GERD and Non-Erosive GERD